Every material Form 8-K eHealth, Inc. has filed with the SEC since August 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
eHealth reported third-quarter 2026 results with total revenue of $21.3 million, down 60% from $53.9 million a year earlier, and a GAAP net loss of $35.9 million, compared with a net loss of $31.7 million in the prior-year quarter. The company reiterated its full-year 2026 guidance, which calls for total revenue of $405.0 million to $445.0 million and GAAP net income of $8.0 million to $25.0 million, and it said operating cash flow improved year over year.
Q3 2026 total revenue was $21.3 million versus $53.9 million; adjusted EBITDA was a loss of $39.9 million versus a loss of $34.0 million.
Q3 2026 operating cash flow was a use of $11.2 million, compared with a use of $25.3 million in Q3 2025; year-to-date operating cash flow was $19.6 million.
Full-year 2026 guidance was reiterated: total revenue $405.0 million to $445.0 million, GAAP net income $8.0 million to $25.0 million, adjusted EBITDA $55.0 million to $75.0 million, and operating cash flow $(10.0) million to $12.0 million.
Management said total operating costs and expenses fell 29% to $67.6 million, and it expects more than $60.0 million in annual variable spend reductions.
eHealth received a Nasdaq notice that its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The notice has no immediate effect, and the stock continues to trade on the Nasdaq Global Select Market under EHTH, but the company must regain compliance by April 12, 2027, or face possible delisting.
Notice received October 14, 2026, under Nasdaq Listing Rule 5450(a)(1)
Compliance period runs 180 calendar days, through April 12, 2027
Stock must close at or above $1.00 for at least 10 consecutive business days to regain compliance
Company may seek stockholder approval for a reverse stock split and says there is no assurance it will regain compliance
eHealth reported second-quarter 2026 revenue of $33.6 million, down 45% from $60.8 million a year earlier, as Medicare enrollment volume fell and the company cut marketing spend. The GAAP net loss widened to $23.6 million from $17.4 million, although operating cash flow improved to a $5.0 million outflow from $41.2 million. The company reiterated its full-year 2026 guidance, which it says it expects to achieve, including meaningful year-over-year improvement in operating cash flow.
Q2 2026 total revenue was $33.6 million, down 45% from $60.8 million in Q2 2025.
GAAP net loss was $23.6 million versus $17.4 million a year earlier; adjusted EBITDA loss was $21.8 million versus $14.1 million.
Operating cash flow was $(5.0) million versus $(41.2) million, an improvement of $36.2 million year-over-year.
Full-year 2026 guidance was reiterated: revenue $405.0 million to $445.0 million, GAAP net income $8.0 million to $25.0 million, adjusted EBITDA $55.0 million to $75.0 million, and operating cash flow $(10.0) million to $12.0 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every eHealth, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →